Literature DB >> 28994826

Kidney cancer: Combination of HDAC inhibitor with IL-2 promising.

Clemens Thoma.   

Abstract

Entities:  

Year:  2017        PMID： 28994826     DOI： 10.1038/nrurol.2017.171

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).

Authors:  Roberto Pili; David I Quinn; Hans J Hammers; Paul Monk; Saby George; Tanya B Dorff; Thomas Olencki; Li Shen; Ashley Orillion; Dominick Lamonica; Roberto S Fragomeni; Zsolt Szabo; Alan Hutson; Adrienne Groman; Susan M Perkins; Richard Piekarz; Michael A Carducci
Journal:  Clin Cancer Res       Date:  2017-09-22       Impact factor: 12.531
  1 in total
  1 in total

1.  Molecular Characterization and Clinical Relevance of Lysine Acetylation Regulators in Urological Cancers.

Authors:  Jian Zhang; Chunning Zhang; Huali Jiang; Hualong Jiang; Yawei Yuan
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.